Phosphocitrate prevents disease progression in murine progressive ankylosis

Hollis E. Krug, Maren L. Mahowald, Paul B. Halverson, John D. Sallis, Herman S. Cheung

Research output: Contribution to journalArticle

37 Scopus citations


Objective. Mice with progressive ankylosis, a spontaneous arthropathy, were treated with phosphocitrate (PC) in vivo to determine the effect of PC on disease progression. Methods. Two groups of mice with progressive ankylosis (matched for age, weight, and sex) were treated parenterally for 6 weeks with either PC or saline vehicle. Results. Clinically, histologically, and microradiographically, there were significant differences in disease progression and severity in the PC-treated and the saline-treated mice. Conclusion. PC appears to inhibit disease progression in murine progressive ankylosis.

Original languageEnglish (US)
Pages (from-to)1603-1611
Number of pages9
JournalArthritis & Rheumatism
Issue number11
StatePublished - Nov 1993


ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Cite this